TIPS and refractory ascites. Lessons from the recent history of ascites therapyARROYO, V; GINES, P.Journal of hepatology. 1996, Vol 25, Num 2, pp 221-223, issn 0168-8278Article

Syndrome hépatorénal = Hepatorenal syndromeGINES, P.Réanimation (Paris. 2001). 2002, Vol 11, pp 1s-6s, issn 1624-0693, SUP1Conference Paper

Mechanism of sodium retention and ascites formation in cirrhosisARROYO, V; GINES, P.Journal of hepatology. 1993, Vol 17, pp S24-S28, issn 0168-8278, SUP2Article

Medical treatment of ascitesGINES, P; ARROYO, V.European journal of gastroenterology & hepatology. 1991, Vol 3, Num 10, pp 730-734, issn 0954-691XArticle

Aquaretic agents : a new potential treatment of dilutional hyponatremia in cirrhosisGINES, P; JIMENEZ, W.Journal of hepatology. 1996, Vol 24, Num 4, pp 506-512, issn 0168-8278Article

Renal function abnormalities in cirrhosisARROYO, V; GINES, P.European journal of gastroenterology & hepatology. 1991, Vol 3, Num 10, pp 714-720, issn 0954-691XArticle

Hepatorenal syndromeGINES, P; ARROYO, V.Journal of the American Society of Nephrology. 1999, Vol 10, Num 8, pp 1833-1839, issn 1046-6673Article

Paracentesis in the management of cirrhotic ascitesGINES, P; ARROYO, V.Journal of hepatology. 1993, Vol 17, pp S14-S18, issn 0168-8278, SUP2Article

Arteriolar vasodilation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosisARROYO, V; GINES, P.Gastroenterology (New York, NY. 1943). 1992, Vol 102, Num 3, pp 1077-1079, issn 0016-5085Article

Prostaglandins and the treatment of hepatorenal syndrome in cirrhosisARROYO, V; GINES, P.Journal of hepatology. 1990, Vol 11, Num 2, pp 142-144, issn 0168-8278, 3 p.Article

Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosisMARTIN, P.-Y; GINES, P; SCHRIER, R. W et al.The New England journal of medicine. 1998, Vol 339, Num 8, pp 533-541, issn 0028-4793Article

Treatment of ascites in patients with cirrhosis of the liverARROYO, V; GINES, P; RODES, J et al.Journal of hepatology. 1986, Vol 2, Num 3, pp 504-512, issn 0168-8278Article

Ascites and hepatorenal syndrome : Pathogenesis and treatment strategiesGINES, P; ARROYO, V; RODES, J et al.Advances in internal medicine. 1998, Vol 43, pp 99-142, issn 0065-2822Article

Pharmacotherapy of ascites associated with cirrhosisGINES, P; ARROVO, V; RODES, J et al.Drugs (Basel). 1992, Vol 43, Num 3, pp 316-332, issn 0012-6667Article

Practical recommendations for the treatment of ascites and its complicationsBATALLER, R; GINES, P; ARROYO, V et al.Drugs (Basel). 1997, Vol 54, Num 4, pp 571-580, issn 0012-6667Article

Management of ascites in cirrhosisBATALLER, R; ARROYO, V; GINES, P et al.Journal of gastroenterology and hepatology. 1997, Vol 12, Num 11, pp 723-733, issn 0815-9319Article

Contraction of human hepatic stellate cells activated in culture : a role for voltage-operated calcium channelsBATALLER, R; NICOLAS, J. M; RODES, J et al.Journal of hepatology. 1998, Vol 29, Num 3, pp 398-408, issn 0168-8278Article

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansionGUEVARA, M; GINES, P; FERNANDEZ-ESPARRACH, G et al.Hepatology (Baltimore, Md.). 1998, Vol 27, Num 1, pp 35-41, issn 0270-9139Article

Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosisSALO, J; GINES, A; RODES, J et al.Journal of hepatology. 1997, Vol 27, Num 4, pp 645-653, issn 0168-8278Article

Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal supine plasma renin, aldosterone, and norepinephrine levelsSALO, J; GINES, A; ANIBARRO, L et al.Hepatology (Baltimore, Md.). 1995, Vol 22, Num 2, pp 479-487, issn 0270-9139Article

Oral misoprostol or intravenous prostaglandin E₂ do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failureGINES, A; SALMERON, J. M; GINES, P et al.Journal of hepatology. 1993, Vol 17, Num 2, pp 220-226, issn 0168-8278Article

Prostaglandin precursor fatty acids in cirrhosis with ascites: effect of linoleic acid infusion in functional renal failureRIMOLA, A; GINES, P; CUSO, E et al.Clinical science (1979). 1988, Vol 74, Num 6, pp 613-619, issn 0143-5221Article

Prognostic value of arterial pressure, endogeneous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascitesLLACH, J; GINES, P; ARROYO, V et al.Gastroenterology (New York, NY. 1943). 1988, Vol 94, Num 2, pp 482-487, issn 0016-5085Article

Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascitesQUINTERO, E; GINES, P; ARROYA, V et al.Nephron. 1986, Vol 42, Num 4, pp 298-303, issn 0028-2766Article

Paracentesis versus diuretics in the treatment of cirrhotics with tense ascitesQUINTERO, E; ARROYO, V; BORY, F et al.Lancet (British edition). 1985, Num 8429, pp 611-612, issn 0140-6736Article